D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ACHC holding history
Acadia Healthcare Company, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACHC overviewAll 13F holders of ACHCFull Q2 2026 holdings
- Shares (Q2 2026)
- 55,336
- Value
- $1.63M
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 55,336 | $1.63M | <0.1% | −39,385−41.6% | Reduced | Holders |
| Q1 2026 | 94,721 | $2.22M | <0.1% | −973,443−91.1% | Reduced | Holders |
| Q4 2025 | 1,068,164 | $15.2M | <0.1% | −1,130,925−51.4% | Reduced | Holders |
| Q3 2025 | 2,199,089 | $54.4M | <0.1% | +571,283+35.1% | Added | Holders |
| Q2 2025 | 1,627,806 | $36.9M | <0.1% | +563,945+53.0% | Added | Holders |
| Q1 2025 | 1,063,861 | $32.3M | <0.1% | +520,515+95.8% | Added | Holders |
| Q4 2024 | 543,346 | $21.5M | <0.1% | +453,093+502.0% | Added | Holders |
| Q3 2024 | 90,253 | $5.72M | <0.1% | +57,495+175.5% | Added | Holders |
| Q2 2024 | 32,758 | $2.21M | <0.1% | −106,988−76.6% | Reduced | Holders |
| Q1 2024 | 139,746 | $11.1M | <0.1% | +7,733+5.9% | Added | Holders |
| Q4 2023 | 132,013 | $10.3M | <0.1% | +29,423+28.7% | Added | Holders |
| Q3 2023 | 102,590 | $7.21M | <0.1% | −16,083−13.6% | Reduced | Holders |
| Q2 2023 | 118,673 | $9.45M | <0.1% | +46,761+65.0% | Added | Holders |
| Q1 2023 | 71,912 | $5.20M | <0.1% | +45,782+175.2% | Added | Holders |
| Q4 2022 | 26,130 | $2.15M | <0.1% | +11,181+74.8% | Added | Holders |
| Q3 2022 | 14,949 | $1.17M | <0.1% | +5,965+66.4% | Added | Holders |
| Q2 2022 | 8,984 | $608.0K | <0.1% | −99,059−91.7% | Reduced | Holders |
| Q1 2022 | 108,043 | $7.08M | <0.1% | +96,202+812.4% | Added | Holders |
| Q4 2021 | 11,841 | $719.0K | <0.1% | +11,841 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −16,003−100.0% | Sold out | Holders |
| Q2 2021 | 16,003 | $1.00M | <0.1% | −141,686−89.9% | Reduced | Holders |
| Q1 2021 | 157,689 | $9.01M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.